Regional analysis of drug treatment prevalence and medication of diabetes mellitus in Germany;Regionale Analyse der medikamentösen Behandlungsprävalenz und Arzneimitteltherapie von Diabetes mellitus in Deutschland

Deutsche Medizinische Wochenschrift

Volumn 137, Issue 46, 2012, Pages 2363-2368

  Willert, T ^a   Walker, J ^b   Schramm, W ^a  

^a HEILBRONN UNIVERSITY   (Germany)

^b IQVIA   (United States)

Author keywords

diabetes mellitus; drug treatment prevalence; Germany; regional; therapy

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ARTICLE; DIABETES MELLITUS; GERMANY; HEALTH INSURANCE; HUMAN; INSULIN TREATMENT; PREVALENCE;

DIABETES MELLITUS; GEOGRAPHY, MEDICAL; GERMANY; HUMANS; HYPOGLYCEMIC AGENTS; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS; PREVALENCE; REGIONAL MEDICAL PROGRAMS;

EID: 84868323045     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0032-1327273     Document Type: Article

References (18)

1. Bundesgesetzblatt Teil I Gesetz zur Verbesserung der Versorgungsstrukturen in der gesetzlichen Krankenversicherung (GKV-Versorgungsstrukturgesetz - GKV-VStG). 2011; Nr. 70 2983 3022
2. Bundesministerium für Gesundheit Mitgliederstatistik KM6. 2008; http://bmg.bund.de/fileadmin/dateien/Downloads/Statistiken/GKV/ Mitglieder-Versicherte/KM6-juli-08.xls [accessed December 21, 2011]
3. Hauner H. Epidemiologie und Kostenaspekte des Diabetes in Deutschland. Dtsch Med Wochenschr: 2005; 130 02 64 65
4. Hauner H., Hanisch J., Bramlage P. et al. Prevalence of undiagnosed Type-2-diabetes mellitus and impaired fasting glucose in German primary care: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS). Exp Clin Endocrinol Diabetes: 2008; 116 18 25 (Pubitemid 351270904)
5. Hauner H., Köster I., Schubert I. Trends in der Prävalenz und ambulanten Versorgung von Menschen mit Diabetes mellitus: Eine Analyse der Versichertenstichprobe AOK Hessen/KV Hessen im Zeitraum von 1998 bis 2004. Dtsch Arztebl: 2007; 104 A 2799
6. Hauner H., Koster I., von Ferber L. Prävalenz des Diabetes mellitus in Deutschland 1998-2001. Sekundärdatenanalyse einer Versichertenstichprobe der AOK Hessen/KV Hessen. Dtsch Med Wochenschr: 2003; 128 2632 2637 (Pubitemid 38021441)
7. Heidemann C., Kroll L., Icks A. et al. Prevalence of known diabetes in German adults aged 25-69 years: results from national health surveys over 15 years. Diabet Med: 2009; 26 655 658
8. Kurth B-M. Beiträge zur Gesundheitsberichterstattung des Bundes - DEGS-Studie zur Gesundheit Erwachsener in Deutschland: Projektbeschreibung. 1. Aufl. Berlin Robert Koch-Institut: 2009
9. Meisinger C., Heier M., Doering A. et al. Prevalence of Known Diabetes and Antidiabetic Therapy Between 1984/1985 and 1999/2001 in Southern Germany. Diabetes Care: 2004; 27 2985 2987 (Pubitemid 39565073)
10. Meisinger C., Strassburger K., Heier M. et al. Prevalence of undiagnosed diabetes and impaired glucose regulation in 35-59-year-old individuals in Southern Germany: the KORA F4 Study. Diabet Med: 2010; 27 360 362
11. Rathmann W., Haastert B., Icks A. et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia: 2003; 46 182 189 (Pubitemid 36343881)
12. Rothe U., Muller G., Schwarz P. E. et al. Evaluation of a diabetes management system based on practice guidelines, integrated care, and continuous quality management in a Federal State of Germany: a population-based approach to health care research. Diabetes Care: 2008; 31 863 868
13. Schipf S., Werner A., Tamayo T. et al. Regional differences in the prevalence of known type 2 diabetes mellitus in 45-74 years old individuals: Results from six population-based studies in Germany (DIAB-CORE Consortium). Diabet Med: 2012; 29 e88 95
14. Schulze M. B., Rathmann W., Giani G. et al. Diabetesprävalenz: Verlässliche Schätzungen stehen noch aus. Deutsches Ärzteblatt: 2010; 107 A 1694 1696
15. Schulze M. B., Schulz M., Heidemann C. et al. Carbohydrate intake and incidence of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Br J Nutr: 2008; 99 1107 1116
16. Siewert U., Fendrich K., Doblhammer-Reiter G. et al. Health care consequences of demographic changes in Mecklenburg-West Pomerania: projected case numbers for age-related diseases up to the year 2020, based on the Study of Health in Pomerania (SHIP). Dtsch Arztebl Int: 2010; 107 328 334
17. Thefeld W. Prävalenz des Diabetes mellitus in der erwachsenen Bevölkerung Deutschlands. Gesundheitswesen: 1999; 61 Spec No 85 89
18. WHO Collaborating Centre for Drug Statistics Methodology ATC classification index with DDDs, 2012. Oslo: 2011